Cargando…
Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy
BACKGROUND: Checkpoint inhibitors show impressive and durable responses in various cancer types and provide new avenues for cancer immunotherapy. However, these drugs have a variety of adverse events. Common autoimmune-related adverse effects include fatigue, hepatitis, skin rash, endocrine deficien...
Autores principales: | Bolz, Saskia, Ramakrishnan, Thivyah, Fleischer, Michael, Livingstone, Elisabeth, Stolte, Benjamin, Thimm, Andreas, Kizina, Kathrin, Ugurel, Selma, Kleinschnitz, Christoph, Glas, Martin, Zimmer, Lisa, Hagenacker, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876540/ https://www.ncbi.nlm.nih.gov/pubmed/33604462 http://dx.doi.org/10.1016/j.ensci.2021.100324 |
Ejemplares similares
-
Neurofilament Heavy Chain and Tau Protein Are Not Elevated in Cerebrospinal Fluid of Adult Patients with Spinal Muscular Atrophy during Loading with Nusinersen
por: Totzeck, Andreas, et al.
Publicado: (2019) -
Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parameters
por: Stolte, Benjamin, et al.
Publicado: (2021) -
Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study
por: Totzeck, Andreas, et al.
Publicado: (2021) -
Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular Atrophy
por: Kizina, Kathrin, et al.
Publicado: (2019) -
Assessment of Bulbar Function in Adult Patients with 5q-SMA Type 2 and 3 under Treatment with Nusinersen
por: Brakemeier, Svenja, et al.
Publicado: (2021)